€14.05
0.50% yesterday
Xetra, Nov 22, 05:35 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Target price 2024 - Analyst rating & recommendation

CompuGroup Medical Classifications & Recommendation:

Buy
56%
Hold
44%

CompuGroup Medical Price Target

Target Price €22.17
Price €14.05
Potential
Number of Estimates 9
9 Analysts have issued a price target CompuGroup Medical 2025 . The average CompuGroup Medical target price is €22.17. This is higher than the current stock price. The highest price target is
€31.00 120.64%
register free of charge
, the lowest is .
A rating was issued by 9 analysts: 5 Analysts recommend CompuGroup Medical to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CompuGroup Medical stock has an average upside potential 2025 of . Most analysts recommend the CompuGroup Medical stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion € 1.19 1.16
5.13% 2.19%
EBITDA Margin 22.81% 19.56%
7.86% 14.27%
Net Margin 3.83% 4.57%
40.63% 19.21%

9 Analysts have issued a sales forecast CompuGroup Medical 2024 . The average CompuGroup Medical sales estimate is

€1.2b
Unlock
. This is
0.81% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€1.2b 1.20%
Unlock
, the lowest is
€1.1b 0.27%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €1.2b 5.13%
2024
€1.2b 2.19%
Unlock
2025
€1.2b 2.72%
Unlock
2026
€1.2b 3.02%
Unlock

9 Analysts have issued an CompuGroup Medical EBITDA forecast 2024. The average CompuGroup Medical EBITDA estimate is

€227m
Unlock
. This is
4.95% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€240m 0.43%
Unlock
, the lowest is
€206m 13.83%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €271m 13.39%
2024
€227m 16.13%
Unlock
2025
€242m 6.41%
Unlock
2026
€254m 5.12%
Unlock
2027
€259m 1.89%
Unlock
2028
€265m 2.32%
Unlock

EBITDA Margin

2023 22.81% 7.86%
2024
19.56% 14.27%
Unlock
2025
20.27% 3.63%
Unlock
2026
20.68% 2.02%
Unlock

8 CompuGroup Medical Analysts have issued a net profit forecast 2024. The average CompuGroup Medical net profit estimate is

€53.1m
Unlock
. This is
109.37% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€70.9m 179.58%
Unlock
, the lowest is
€43.5m 71.42%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €45.5m 37.59%
2024
€53.1m 16.58%
Unlock
2025
€62.0m 16.86%
Unlock
2026
€72.6m 17.07%
Unlock

Net Margin

2023 3.83% 40.63%
2024
4.57% 19.21%
Unlock
2025
5.20% 13.79%
Unlock
2026
5.91% 13.65%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share 0.88 1.03
37.59% 17.05%
P/E 13.69
EV/Sales 1.30

8 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€1.03
Unlock
. This is
110.20% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€1.37 179.59%
Unlock
, the lowest is
€0.84 71.43%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €0.88 37.59%
2024
€1.03 17.05%
Unlock
2025
€1.20 16.50%
Unlock
2026
€1.40 16.67%
Unlock

P/E ratio

Current 28.90 13.07%
2024
13.69 52.63%
Unlock
2025
11.72 14.39%
Unlock
2026
10.01 14.59%
Unlock

Based on analysts' sales estimates for 2024, the CompuGroup Medical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.31 39.91%
2024
1.30 1.12%
Unlock
2025
1.26 2.65%
Unlock
2026
1.22 2.93%
Unlock

P/S ratio

Current 0.63 60.56%
2024
0.63 0.79%
Unlock
2025
0.61 2.65%
Unlock
2026
0.59 2.94%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today